Variant report
Variant | esv3441511 |
---|---|
Chromosome Location | chr1:103203064-103205962 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559985300 | chr1:103203080-103203081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569309717 | chr1:103203094-103203095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138338646 | chr1:103203098-103203099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1376359 | chr1:103203107-103203108 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
5 | rs61812114 | chr1:103203109-103203110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555263872 | chr1:103203114-103203115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548630293 | chr1:103203167-103203168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs147818660 | chr1:103203205-103203206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534869503 | chr1:103203210-103203211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189538198 | chr1:103203228-103203229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571773218 | chr1:103203270-103203271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141490144 | chr1:103203405-103203406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534731907 | chr1:103203417-103203418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557726440 | chr1:103203435-103203436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs367602824 | chr1:103203437-103203438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181879942 | chr1:103203449-103203450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369542934 | chr1:103203490-103203491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376627052 | chr1:103203524-103203525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543045756 | chr1:103203530-103203531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554736857 | chr1:103203553-103203554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552926832 | chr1:103203574-103203575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573303740 | chr1:103203575-103203576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540406675 | chr1:103203581-103203582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115187979 | chr1:103203599-103203600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185425174 | chr1:103203602-103203603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373022769 | chr1:103203632-103203633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544896095 | chr1:103203685-103203686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs578082688 | chr1:103203808-103203809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs74562727 | chr1:103203823-103203824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs147008036 | chr1:103203838-103203839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530381481 | chr1:103203865-103203866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548582138 | chr1:103203867-103203868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs137919769 | chr1:103203871-103203872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9970165 | chr1:103203880-103203881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190772490 | chr1:103203917-103203918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528165056 | chr1:103203938-103203939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149445860 | chr1:103203949-103203950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs72996245 | chr1:103203966-103203967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539244010 | chr1:103203975-103203976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557640373 | chr1:103203979-103203980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569591837 | chr1:103204058-103204059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536615988 | chr1:103204060-103204061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs77470789 | chr1:103204102-103204103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9970452 | chr1:103204212-103204213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181572405 | chr1:103204234-103204235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs540718501 | chr1:103204244-103204245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186354408 | chr1:103204261-103204262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191308996 | chr1:103204300-103204301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143089402 | chr1:103204359-103204360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182935303 | chr1:103204385-103204386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:103203000-103203600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:103203600-103204400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr1:103204400-103204600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr1:103205400-103206200 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr1:103205600-103206000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |